Risk factors

Kalaris faces high-risk merger dynamics with AlloVir, including valuation adjustments, termination fees, and stockholder dilution. The company is heavily dependent on future financing, regulatory approvals, and competitive pressures in the biotech sector. Clinical-stage development carries substantial risks of failure, trial delays, and uncertain market acceptance.

Lifeward faces going concern doubts with an accumulated deficit of $264.8 million as of December 31, 2024. Operations depend on third-party manufacturing partners like Sanmina and Cirtronics for ReWalk and AlterG products. The company must maintain Nasdaq listing requirements while pursuing regulatory clearances and market reimbursement for devices like ReBoot.

El Pollo Loco faces heavy geographic concentration in Los Angeles, which generated about 72% of fiscal 2024 revenue. Labor shortages, rising minimum wages, and commodity costs like chicken heavily pressure restaurant profitability. Franchisees operate roughly 65% of restaurants, creating reliance on their financial health and operational execution.

Heavy reliance on clinical success and FDA approval for drug candidates like pilavapadin, LX9851, and sotagliflozin.

908 Devices is heavily reliant on government contracts and channel partners for revenue distribution. Protection of proprietary technology and patents is critical to market success. Manufacturing operations are heavily concentrated in just two physical locations.

Geographic concentration in Western U.S. metro areas exposes the bank to regional economic and real estate downturns.

First Western Financial faces geographic concentration risks in five western states, with heavy reliance on real estate collateral and wealth management fees.

International operations account for 51.8% of 2024 revenue, while 75% of employees are located abroad.

Concentrated in construction, commercial real estate, and structured finance loans within Greater Boston.

Restaurant operations depend on managing food costs, labor availability, and long-term lease commitments.

Nidok relies heavily on property and casualty insurance, independent and captive agents, and federal multi-peril crop programs. Financial results face exposure to weather catastrophes, crop volatility, reinsurance costs, and AM Best rating changes. Control rests largely with Nodak Mutual Group.

Sales heavily rely on TracPipe and CounterStrike CSST systems with independent sales organizations and wholesale stocking distributors. Manufacturing is concentrated in Exton, Pennsylvania, utilizing stainless steel and copper alloy. Litigation risks involve repeat pattern claims relating to flexible gas piping products. Directors and officers own approximately 65 percent of common stock.